ECLCX
Price
$29.14
Change
+$0.23 (+0.80%)
Updated
Jun 6 closing price
Net Assets
414.44M
GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
304.87B
Interact to see
Advertisement

ECLCX vs GAFFX

Header iconECLCX vs GAFFX Comparison
Open Charts ECLCX vs GAFFXBanner chart's image
Eaton Vance Growth C
Price$29.14
Change+$0.23 (+0.80%)
VolumeN/A
Net Assets414.44M
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets304.87B
ECLCX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ECLCX vs. GAFFX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECLCX is a Buy and GAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. ECLCX (414M). GAFFX pays higher dividends than ECLCX: GAFFX (0.65) vs ECLCX (0.00). ECLCX was incepted earlier than GAFFX: ECLCX (23 years) vs GAFFX (8 years). ECLCX (1.79) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. ECLCX (18.00). ECLCX has a lower initial minimum investment than GAFFX: ECLCX (1000) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. ECLCX (2.52). GAFFX return over 5 years is better than : 47.05 vs. ECLCX (19.36).
ECLCXGAFFXECLCX / GAFFX
Total Expense Ratio1.790.30597%
Annual Report Gross Expense Ratio1.790.30597%
Fund Existence23 years8 years-
Gain YTD1.2615.64022%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets414M305B0%
Annual Yield % from dividends0.000.65-
Returns for 1 year2.529.7426%
Returns for 3 years23.1338.5660%
Returns for 5 years19.3647.0541%
Returns for 10 years47.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc